Top Markets
#1 Islamic Coin Islamic Coin +151.57%
#2 Black Phoenix Black Phoenix +35.20%
#3 Velvet Velvet +24.01%
#4 Akedo Akedo +19.95%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.32%
#6 Fake World Assets Fake World Assets +16.68%
#7 DoubleZero DoubleZero +13.22%
#8 clBTC clBTC +11.84%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +11.39%
#10 HOME HOME +10.84%
Coin of the day
Islamic Coin Islamic Coin
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Bioasis Technologies Inc. Bioasis Technologies Inc.

Bioasis Technologies Inc.

BTI
Classifica tra le azioni #39944
Bioasis Technologies Inc. is a development-stage biopharmaceutical firm focused... Bioasis Technologies Inc. is a development-stage biopharmaceutical firm focused on innovating diagnostic methods and therapeutic solutions for a range of neurological conditions. The company's primary technological asset is the xB3 platform, engineered to enable the transport of medicinal compounds across the often-impenetrable blood-brain barrier. This capability is crucial for addressing central nervous system disorders, including various brain cancers, metabolic dysfunctions, and neurodegenerative illnesses. Bioasis is actively advancing its in-house pipeline with programs such as xB3-001 for brain metastases, xB3-002 for glioblastoma, and xB3-007 for neurodegenerative diseases, all designed to offer both symptomatic relief and disease-modifying benefits. The company has also established numerous strategic alliances. These include a partnership with Aposense Limited to deliver siRNA therapeutics for CNS disorders; a collaboration with Oxyrane UK Ltd. to combine the xB3 technology with Oxyrane's OxyCAT platform for enhanced enzyme replacement therapy targeting the brain; an agreement with Janssen Biotech, Inc. for the discovery, development, and commercialization of novel products leveraging the xB3 platform; and a research and licensing deal with Neuramedy Co Ltd. to develop and market an xB3-enhanced version of their antibody, Tomaralimab. Founded in 2006, Bioasis Technologies Inc. is headquartered in New Haven, Connecticut.
Prezzo delle azioni
$0.00366968
Ultima sincronizzazione: 2024-07-23
Capitalizzazione di mercato
$291.42K
Variazione (1 giorno)
-0.81%
Variazione (1 anno)
0.00%
Paese
US
Scambia Bioasis Technologies Inc. (BTI)

Categoria

Healthcare
Il prezzo BTI con la capitalizzazione del mercato della B
Bioasis Technologies Inc. Bioasis Technologies Inc.
BTI
$0.00366968
Capitalizzazione di mercato di Bioasis Technologies Inc.(BTI)
Capitalizzazione di mercato: $291.42K
A partire dal August 2026, Bioasis Technologies Inc. ha una capitalizzazione di mercato pari a $291.42K. Questo rende Bioasis Technologies Inc. la 39944th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di Bioasis Technologies Inc. dal 2008 al 2026
BTI in paragone con la classifica dei più popolari stocks
Il prezzo per BTI Attivo B Capitalizzazione del mercato a B Risultati
Bioasis Technologies Inc. Bioasis Technologies Inc.
$68,873.72 $291.42K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.470T +1,876,829,455.54%
Bioasis Technologies Inc. Bioasis Technologies Inc.
$56,250.42 $291.42K
Apple Inc. Apple Inc.
AAPL
$4.467T +1,532,840,809.29%
Bioasis Technologies Inc. Bioasis Technologies Inc.
$52,564.87 $291.42K
Alphabet Inc. Alphabet Inc.
GOOG
$4.174T +1,432,408,272.84%
Bioasis Technologies Inc. Bioasis Technologies Inc.
$46,592.25 $291.42K
Microsoft Corporation Microsoft Corporation
MSFT
$3.700T +1,269,652,791.00%
Bioasis Technologies Inc. Bioasis Technologies Inc.
$35,942.56 $291.42K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.854T +979,445,505.37%